With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

The 19th century was a period of immense innovation for medicine in Scotland, marked by breakthroughs in anaesthetics, ...

However, the UK’s innovative ‘Netflix style’ subscription model for antibiotics represents a groundbreaking approach to ...

Content review in pharma – often referred to as CMLR or med-legal or promotional review – is a critical process. It ensures ...

Delivering the right treatment at the right time to the right patient in an affordable way is the ambition of medical affairs ...

Bill Berry, general manager life sciences and healthcare at Constellation and former head of US general medicines business ...

Aqneursa has been approved to treat neurological symptoms associated with NPC in children and adults who weigh at least 15kg, ...

It's another setback for the LAG-3 category in MSS colorectal cancer, coming after Bristol-Myers Squibb's combination of PD-1 ...

It's a blow to the SCD community, as Oxbryta (voxelotor) was the first drug to reach the market that prevented sickle ...

Flagship Pioneering's latest biotech launch, Mirai Bio, aims to help genetic medicine developers find the best way to get ...

BioAge Labs has completed its upsized initial public offering (IPO), raising $198 million after increasing the number of ...

AstraZeneca's EGFR inhibitor Tagrisso has been approved by the FDA for a new lung cancer indication that could make it a ...